ENTITY
Golden Meditech

Golden Meditech (801 HK)

21
Analysis
Health Care • China
Golden Meditech is an integrated healthcare enterprise in China, engaged in the development, manufacture, and sale of medical devices, particularly blood-related technologies. The company also provides hospital management services, medical insurance administration, Chinese herbal medicines, and cell and tissue storage and genetic testing services. Golden Meditech was incorporated in 2001 and is headquartered in Hong Kong.
more
bearish•Golden Meditech
•15 Feb 2017 23:35

Golden Meditech - Cash Position Will Soon Be Greater than Market Cap... But Is This a Value Trap?

On 13 January 2017, Golden Meditech Holdings Ltd ("GMH", 801 HK) announced an offer from Magnus Opus (the "Offeror") The voluntary conditional...

Share
•27 Oct 2015 11:03

QUICKNOTE: Golden Meditech and Nanjing Xinjiekou Team Up

The China Cord Blood bidding process continues to evolve in unexpected ways with Golden Meditech announcing an MOU with Nanjing Xinjiekou. We...

Share
•17 Sep 2015 05:00

QUICKNOTE: Cordlife Holders Vote in Favor of Golden Meditech Deal

Cordlife Group's (CLGL:SP) shareholders voted overwhelmingly in favor of selling the company's holdings of China Cord Blood (CO:US) to Golden...

Share
•10 Sep 2015 04:01

Update: Zhongyuan Drops Out of the Bidding

Zhongyuan Union & Cell Engineering Corp (600645: Shanghai) has dropped out of the bidding process for China Cord Blood (CO:US), citing the...

Share
•28 Aug 2015 05:02

Update: Mr. Kam Raises His Stake, and Nanjing Xinjiekou Ups the Pressure

The bidding war for China Cord Blood has heated up. China Cord Blood's Chairman has acquired KKR's 19% stake through a restructured purchase...

Share
x